Abdul is currently the Risk, Response and Insights Director of Global Clinical Operations at Novartis. Abdul brings a wealth of experience in risk, internal audit, internal controls, and overall assurance. His career has focused on public protection, spanning counter-terrorism (explosives and weapons detection), food safety regulatory risks, systemic regulatory risks on GCSE and A-level exams delivery, rail transport risks, public health risks, social housing provision risks, and on built and natural environment risks. He is a member of the ESG Committee of the Institute of Risk Management (IRM), and also a BAME mentor in the global INvolve programme